Search research articles
Contact Us
Filters
Showing results (251-260 of 333) with videos related to
Page
of 34
Sort By:
Academic Medicine : Journal of the Association of American Medical Colleges
|
June 4, 1998
Injury-control education in six U.S. medical schools
R N Butler, K H Todd, A L Kellermann, et al.
Leukemia & Lymphoma
|
June 5, 1998
Chromosome breaks and sister chromatid exchange as predictors of second cancers in Hodgkin's disease
S S Strom, Y Gu, A J Sigurdson, et al.
British Journal of Haematology
|
December 19, 1998
Paclitaxel plus high-dose cyclophosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin's lymphoma
A Younes, J Romaguera, O Mesina, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 15, 2001
Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse
W S Liu, C Pesold, M A Rodriguez, et al.
Leukemia & Lymphoma
|
February 26, 1999
Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma
J E Romaguera, F B Hagemeister, P McLaughlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion schedule
A Younes, J P Ayoub, F B Hagemeister, et al.
Cancer
|
July 21, 1998
Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members
P Watson, K M Lin, M A Rodriguez-Bigas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 1992
Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma
J R Redman, F Cabanillas, W S Velasquez, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 10, 2000
Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas
P J Schlembach, R B Wilder, S L Tucker, et al.
Clinical Lymphoma
|
November 15, 2001
Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy?
C Visco, L J Medeiros, O M Mesina, et al.
Page
of 34
Search research articles
Search
Showing results (251-260 of 333) with videos related to
Sort By:
Page
of 34
Academic Medicine : Journal of the Association of American Medical Colleges
|
June 4, 1998
Injury-control education in six U.S. medical schools
R N Butler, K H Todd, A L Kellermann, et al.
Leukemia & Lymphoma
|
June 5, 1998
Chromosome breaks and sister chromatid exchange as predictors of second cancers in Hodgkin's disease
S S Strom, Y Gu, A J Sigurdson, et al.
British Journal of Haematology
|
December 19, 1998
Paclitaxel plus high-dose cyclophosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin's lymphoma
A Younes, J Romaguera, O Mesina, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 15, 2001
Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse
W S Liu, C Pesold, M A Rodriguez, et al.
Leukemia & Lymphoma
|
February 26, 1999
Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma
J E Romaguera, F B Hagemeister, P McLaughlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion schedule
A Younes, J P Ayoub, F B Hagemeister, et al.
Cancer
|
July 21, 1998
Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members
P Watson, K M Lin, M A Rodriguez-Bigas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 1992
Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma
J R Redman, F Cabanillas, W S Velasquez, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 10, 2000
Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas
P J Schlembach, R B Wilder, S L Tucker, et al.
Clinical Lymphoma
|
November 15, 2001
Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy?
C Visco, L J Medeiros, O M Mesina, et al.
Page
of 34